Weinmann-Menke, Julia; Anders, Hans-Joachim; Floege, Juergen
Rare glomerular diseasesNEPHROLOGIE. Bd. 18. H. 5. 2023 S. 265-266
Moehler, Markus H.; Kato, Ken; Arkenau, Hendrik-Tobias et al.
Rationale 305: Phase 3 study of tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment (1L) of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. 2023 S. 286-286
Frommer, Lara; Koenig, Jochem; Chatzidou, Sofia et al.
Recurrence risk of autoimmune thyroid and endocrine diseasesBEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 37. H. 2. 2023
Hoybye, Charlotte; Biller, Beverly M. K.; Ferran, Jean-Marc et al.
Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studiesENDOCRINE CONNECTIONS. Bd. 12. H. 1. 2023
Gerber, Tiemo Sven; Witzel, Hagen Roland; Weinmann, Arndt et al.
Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic CholangiocarcinomaBIOMEDICINES. Bd. 11. H. 9. 2023
Loomba, Rohit; Schattenberg, Joern M.; Taub, Rebecca A. et al.
RELATIONSHIP OF NON-INVASIVE MEASURES WITH HISTOLOGICAL RESPONSE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRO-NASH TRIALHEPATOLOGY. Bd. 78. 2023 S. S155-S159
Labenz, Christian; Lammert, Frank; Galle, Peter R.
Reply to: "SEAL: Why was this approach not effective?"JOURNAL OF HEPATOLOGY. Bd. 78. H. 1. 2023 S. E27-E28
Labenz, Christian; Lammert, Frank; Galle, Peter R.
Reply to: "SEAL: Why was this approach not effective?"JOURNAL OF HEPATOLOGY. Bd. 78. H. 1. 2023 S. E27-E28
Iruzubieta, Paula; Bataller, Ramon; Arias-Loste, Maria Teresa et al.
Research Priorities for Precision Medicine in NAFLDCLINICS IN LIVER DISEASE. Bd. 27. H. 2. 2023 S. 535-551
Chevallay, Mickael; Berlth, Felix; De Manzoni, Giovanni et al.
Resection margin strategy in gastric cancer surgery: the European REMARCS (Resection MARgin for Cancer of the Stomach) surveyBRITISH JOURNAL OF SURGERY. Bd. 110. 2023